bendazac has been researched along with Autoimmune Diseases in 1 studies
bendazac : A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcalde, M | 1 |
| García-Díaz, M | 1 |
| Najarro, F | 1 |
| Pascasio, JM | 1 |
1 other study available for bendazac and Autoimmune Diseases
| Article | Year |
|---|---|
[Toxic and autoimmune type I-like hepatitis and hyporegenerative anemia caused by bendazac].
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Disea | 1994 |